AGESA HAYAT VE EMEKLİLİK A.Ş.

It was previously announced that Medisa Sigorta A.Ş. ("Medisa", formerly: Sabancı Ageas Sağlık Sigorta A.Ş.) participated in the capital increase with emission premium realized by Medisa in order to increase synergy and efficiency in the health insurance sector and acquired 80% of Medisa's shares with a nominal value of TRY 629,000,000 for shares with a nominal value of TRY 400,000,000.

As part of the aforementioned process, pursuant to the Board of Directors' resolution dated 22.11.2024, 100,000,000 shares representing 20% of the capital of Medisa owned by Aksigorta A.Ş. ("Aksigorta") were purchased from Aksigorta for TL 157,250,000, thereby increasing the Company's shareholding to 100%. In this context, a preliminary agreement was signed with Aksigorta on 22.11.2024 and an application was made to the Insurance and Private Pension Regulatory and Supervisory Authority ("SEDDK") for the share transfer transaction. In line with the approval of SEDDK, the share transfer transaction was completed on 20.12.2024 and our Company became the owner of all shares representing Medisa's capital.

Pursuant to the provisions of Article 6 titled "Postponement of Public Disclosure of Inside Information" of the Capital Markets Board's Communiqué on Material Events (II-15.1), although a preliminary agreement has been signed between our Company and Aksigorta for the transfer of shares, since the said transfer transaction is subject to the permission of the SEDDK, a fully binding purchase agreement has not yet been signed and there is no certainty as to whether the transaction will be realized, it has been duly decided to postpone the public disclosure of inside information. In this context, no information has been disclosed to the public until the permission of SEDDK has been obtained and a binding share transfer agreement has been signed.

Respectfully submitted to the attention of the public and our investors.

The Material Event Disclosure has been prepared in Turkish and English and in case of any contradiction between the two texts, the Turkish disclosure shall prevail.